Basking Biosciences - About the company
Basking Biosciences is a series C company based in Columbus (United States), founded in 2019. It operates as a Developer of therapeutics for ischemic stroke treatment. Basking Biosciences has raised $117M in funding from investors like Arch Venture Partners, Broadview Ventures and Rev1 Ventures. The company has 40 active competitors, including 14 funded and 6 that have exited. Its top competitors include companies like Anthos Therapeutics, 4TEEN4 Pharmaceuticals and Bioxodes.
Company Details
Developer of therapeutics for ischemic stroke treatment. It offers a drug candidate BB-031 which is an RNA aptamer that inhibits von Willebrand Factor and has demonstrated potent vessel recanalization. It also offers BB-025 a sequence-specific reversal oligonucleotide that neutralizes the pharmacologic effect of BB-031.
- Website
- www.baskingbiosciences.com/
- Email ID
- *****@baskingbiosciences.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2019
Location
Columbus, United States
Stage
Series C
Total Funding
$117M in 5 rounds
Latest Funding Round
Investors
Ranked
12th among 40 active competitors
Employee Count
15 as on Feb 28, 2026
Similar Companies
Legal entities associated with Basking Biosciences
Basking Biosciences is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Basking Biosciences, Inc CIN: 833414363 , United States, Active | Dec 31, 2018 | - | - | - |
Sign up to download Basking Biosciences' company profile
Basking Biosciences's funding and investors
Basking Biosciences has raised a total funding of $117M over 5 rounds. Its first funding round was on Jun 01, 2020. Its latest funding round was a Series C round on Feb 01, 2024 for $*****. 8 investors participated in its latest round. Basking Biosciences has 11 institutional investors.
Here is the list of recent funding rounds of Basking Biosciences:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 01, 2024 | 6611631 | Series C | 5859271 | 6001370 | 6793769 | 4203022 |
Oct 31, 2023 | 7776863 | Series C | 1622122 | 4327384 | 3999552 | 2293485 |
Dec 07, 2020 | 3641671 | Seed | 5300921 | 2351407 | 4108674 |
Access funding benchmarks and valuations. Sign up today!View details of Basking Biosciences's funding rounds and investors
Basking Biosciences' founders and board of directors
Founder? Claim ProfileBasking Biosciences' employee count trend
Basking Biosciences has 15 employees as of Feb 26. Here is Basking Biosciences's employee count trend over the years:
Uncover Basking Biosciences' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Basking Biosciences's Competitors and alternates
Top competitors of Basking Biosciences include Anthos Therapeutics, 4TEEN4 Pharmaceuticals and Bioxodes. Here is the list of Top 10 competitors of Basking Biosciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Anthos Therapeutics 2019, Cambridge (United States), Acquired | Developer of novel anticoagulants for thrombosis treatment | $250M | 64/100 | |
2nd | 4TEEN4 Pharmaceuticals 2013, Hennigsdorf (Germany), Series C | Developer of therapeutics and diagnosticcs for cardiovascular diseases | $94.4M | 60/100 | |
3rd | Developer of novel peptide therapies for prevention of thrombosis | $45.4M | 57/100 | ||
4th | Remedy Pharmaceuticals 2004, New York City (United States), Acquired | Intravenous formulation for acute central nervous system conditions such as stroke (ischemic and hemorrhagic), traumatic brain injury. | $22.8M | 53/100 | |
5th | CeleCor Therapeutics 2017, San Diego (United States), Series A | Developer of POC subcutaneous injectable for treating myocardial infarction | $46.5M | 52/100 | |
6th |  Remedium Bio 2020, Needham (United States), Seed | Developer of gene therapies for a broad range of diseases | $3.5M | 50/100 | |
7th | Acticor Biotech 2013, Paris (France), Public | Developing immunotherapeutics for treating ischemic stroke | $31.4M | 47/100 | |
8th | Aurum Biosciences 2015, Glasgow (United Kingdom), Series A | A biopharmaceutical company developing novel oxygen carriers and proprietary software for use with MRI, initially for Acute Ischaemic Stroke. | $6.3M | 44/100 | |
9th |  Ever Supreme Bio Technology 2016, Taichung (Taiwan), Public | Developer of immune cell and stem cell therapies for multiple diseases | - | - | 43/100 |
10th | Developer of small molecule based therapeutics for the treatment of stroke recovery | - | 42/100 | ||
12th |  Basking Biosciences 2019, Columbus (United States), Series C | Developer of therapeutics for ischemic stroke treatment | $117M | 44/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Basking Biosciences's competitors? Click here to see the top ones
Basking Biosciences's Investments and acquisitions
Basking Biosciences has made no investments or acquisitions yet.
News related to Basking Biosciences
•
•
•
RTP-based Basking Biosciences raises $27.5 millionBusiness North Carolina•Nov 16, 2023•Basking Biosciences
•
•
•
•
•
Basking Biosciences, Inc. Completes $5.4M Seed FinancingBusiness Wire•Dec 07, 2020•Basking Biosciences, Broadview Ventures, Rev1 Ventures, Viva BioInnovator
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Basking Biosciences
Explore our recently published companies
- Sino-synergy.com - Funding Raised company
- Reverbtherapeutics.com - 2019 founded, Funding Raised company
- Placy.me - Funding Raised company
- PG Agri Infra - Hyderabad based, 2016 founded, Unfunded company
- Tric Business Solutions - Dehradun based, 2024 founded, Unfunded company
- UnitedCorp - Miami based, 1992 founded, Unfunded company
